These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23467929)
1. Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells. Sun X; Qin S; Fan C; Xu C; Du N; Ren H Oncol Rep; 2013 May; 29(5):2079-87. PubMed ID: 23467929 [TBL] [Abstract][Full Text] [Related]
2. [Role of let-7 in maintaining characteristics of breast cancer stem cells]. Sun X; Fan C; Hu LJ; Du N; Xu CW; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):789-92. PubMed ID: 22863580 [TBL] [Abstract][Full Text] [Related]
3. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Zhao Y; Deng C; Wang J; Xiao J; Gatalica Z; Recker RR; Xiao GG Breast Cancer Res Treat; 2011 May; 127(1):69-80. PubMed ID: 20535543 [TBL] [Abstract][Full Text] [Related]
4. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843 [TBL] [Abstract][Full Text] [Related]
5. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1. Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703 [TBL] [Abstract][Full Text] [Related]
6. Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells. Sun X; Xu C; Tang SC; Wang J; Wang H; Wang P; Du N; Qin S; Li G; Xu S; Tao Z; Liu D; Ren H Cancer Gene Ther; 2016 Apr; 23(4):83-9. PubMed ID: 26987290 [TBL] [Abstract][Full Text] [Related]
7. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer. Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340 [TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115 [TBL] [Abstract][Full Text] [Related]
10. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer. Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194 [TBL] [Abstract][Full Text] [Related]
11. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219 [TBL] [Abstract][Full Text] [Related]
12. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine. Sui M; Jiang D; Hinsch C; Fan W Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437 [TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells]. Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ Ai Zheng; 2006 Aug; 25(8):967-73. PubMed ID: 16965676 [TBL] [Abstract][Full Text] [Related]
14. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382 [TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 promotes secretion of pro-oncogenic immuno-miRNAs and piRNAs. Lü J; Zhao Q; Ding X; Guo Y; Li Y; Xu Z; Li S; Wang Z; Shen L; Chen HW; Yu Z; Pestell RG Clin Sci (Lond); 2020 Apr; 134(7):791-805. PubMed ID: 32219337 [TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells. Lu IF; Hasio AC; Hu MC; Yang FM; Su HM J Nutr Biochem; 2010 Jun; 21(6):512-7. PubMed ID: 19369047 [TBL] [Abstract][Full Text] [Related]
17. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line. García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930 [TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway. Yuan L; Jiang R; Yang Y; Ding S; Deng H Oncol Rep; 2012 Dec; 28(6):2131-7. PubMed ID: 22971613 [TBL] [Abstract][Full Text] [Related]
19. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214 [TBL] [Abstract][Full Text] [Related]
20. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression. Zhang B; Zhang X; Tang B; Zheng P; Zhang Y Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]